Jonathan Knutzen Sells 296 Shares of Palomar (NASDAQ:PLMR) Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) insider Jonathan Knutzen sold 296 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $127.75, for a total transaction of $37,814.00. Following the completion of the transaction, the insider directly owned 28,250 shares of the company’s stock, valued at $3,608,937.50. This trade represents a 1.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Palomar Stock Up 0.9%

Shares of PLMR opened at $130.09 on Friday. The company has a quick ratio of 0.50, a current ratio of 0.50 and a debt-to-equity ratio of 0.30. The company has a 50-day moving average price of $130.76 and a two-hundred day moving average price of $123.92. The stock has a market cap of $3.42 billion, a price-to-earnings ratio of 17.49 and a beta of 0.40. Palomar Holdings, Inc. has a 12 month low of $100.81 and a 12 month high of $147.62.

Palomar (NASDAQ:PLMR) last released its quarterly earnings data on Tuesday, August 4th. The company reported $2.36 earnings per share for the quarter, beating the consensus estimate of $2.19 by $0.17. Palomar had a return on equity of 23.28% and a net margin of 18.61%.The company had revenue of $314.42 million for the quarter, compared to analyst estimates of $621.52 million. During the same period in the prior year, the company posted $1.76 EPS. Equities analysts predict that Palomar Holdings, Inc. will post 9.21 EPS for the current fiscal year.

Palomar Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 2nd. Investors of record on Wednesday, August 19th will be paid a $0.45 dividend. The ex-dividend date of this dividend is Wednesday, August 19th. This represents a $1.80 annualized dividend and a yield of 1.4%. Palomar’s payout ratio is currently 24.19%.

Key Stories Impacting Palomar

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Strong premium growth and expansion in specialty insurance are expected to support Palomar’s earnings momentum. Analysts’ average price target of $162.75 and recent target increases reinforce the bullish view. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
• Positive Sentiment: Dowling & Partners expressed a positive view of Palomar’s fiscal 2026 earnings outlook, adding to expectations for continued profit growth. DOWLING & PARTN Has Positive View of Palomar FY2026 Earnings
• Positive Sentiment: Palomar’s latest quarterly results provide fundamental support: earnings per share of $2.36 exceeded the $2.19 consensus estimate, while profitability and return on equity remained strong.
• Neutral Sentiment: Several insiders, including the president, CFO and Jonathan Knutzen, sold relatively small portions of their holdings to cover tax withholding on vested equity awards. Because the transactions were not discretionary sales, they are less negative than typical insider selling, though they may limit near-term sentiment.
• Neutral Sentiment: Palomar declared a quarterly dividend of $0.45, equivalent to $1.80 annually and a yield of approximately 1.4%, providing modest shareholder support.
• Negative Sentiment: Competitive pricing could reduce premium profitability, while a higher combined ratio would pressure underwriting margins. These risks may temper the market’s response to otherwise strong growth expectations. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?

Institutional Investors Weigh In On Palomar

Institutional investors have recently modified their holdings of the business. Geneos Wealth Management Inc. bought a new stake in shares of Palomar during the fourth quarter worth approximately $32,000. Kestra Advisory Services LLC bought a new position in Palomar in the fourth quarter valued at approximately $33,000. Rockefeller Capital Management L.P. boosted its stake in Palomar by 81.5% in the fourth quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock valued at $40,000 after acquiring an additional 132 shares during the last quarter. Quantbot Technologies LP acquired a new stake in Palomar during the 2nd quarter worth $43,000. Finally, Frazier Financial Advisors LLC acquired a new stake in Palomar during the 4th quarter worth $54,000. Institutional investors and hedge funds own 90.25% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Keefe, Bruyette & Woods increased their price objective on Palomar from $166.00 to $167.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Piper Sandler boosted their target price on shares of Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Zacks Research lowered shares of Palomar from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th. Weiss Ratings upgraded shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, June 18th. Finally, Evercore set a $152.00 target price on shares of Palomar in a research report on Friday, July 10th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $162.75.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.